As of 4:00pm ET
| +0.30 / +0.37%|
The 4 analysts offering 12-month price forecasts for Madrigal Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 82.00 and a low estimate of 54.00. The median estimate represents a -21.07% decrease from the last price of 81.08.
The current consensus among 4 polled investment analysts is to Buy stock in Madrigal Pharmaceuticals Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.